Xenogen Corp.

Maker of drug discovery systems reports second quarter total revenue up 30%

Published in Hospital and Nursing Home Week, September 8th, 2005

Xenogen Corporation (XGEN), maker of imaging systems including instruments, biological solutions and software to accelerate drug discovery and development, reported financial results for the second quarter and 6 months ended June 30, 2005.

Total revenue for the second quarter of 2005 was $9.7 million, a 30% increase over 2004 second quarter revenue of $7.5 million. The revenue growth reflects increased sales in all lines of Xenogen's business, especially sales of IVIS units which accounted for 59% of total growth over the prior year quarter.

Loss from operations for the second quarter of 2005 was approximately $3.6 million, compared to a loss from...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week

Source: Hospital and Nursing Home Week (2005-09-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry